Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Jason Boehm (Fed)
Director, Program Coordination Office
Dr. Boehm is Director of the NIST Program Coordination Office with 12 years of budget, policy, and planning experience. In this role Dr. Boehm serves as the primary technical advisor and consultant to the NIST Director and Associate Director for Laboratory Programs carrying out planning and review of NIST R&D programs in areas of strategic importance to the agency and Administration, the development and implementation of strategic programs for the institute, and the representation of NIST’s interests on boards, committees and inter-agency policy fora.
Dr. Boehm came to NIST from the Office of Science and Technology Policy (OSTP), Executive Office of the President, where he was responsible for consultation, analysis, and policy development regarding science and technology related to multiple issues of homeland and national security including the development of medical and non-medical countermeasures against WMD, domestic nuclear defense, engineered threats and emerging infectious diseases, and biological and chemical agent decontamination, nuclear defense and detection, international collaborations on homeland security-related S&T, and a number of other issues. Dr. Boehm originally joined OSTP as a AAAS/NTI Fellow in Global Security, an award that provided him the opportunity to work anywhere within the U.S. government on issues related to biological terrorism.
Prior to joining the federal government Dr. Boehm was involved in cancer research at Cornell University, where he led a team of researchers studying the role of the cellular protein tissue transglutaminase in cell survival and tumorigenesis. Dr. Boehm received his Ph.D. in 2000 from the University of Nebraska Medical Center, Eppley Institute for Cancer Research, where he studied the role of receptor tyrosine kinase signaling in cell survival.